The introduction of ethambutol in TB treatment regimens has had a profound impact on the epidemiology of the disease. By effectively treating TB and preventing the development of drug resistance, ethambutol has contributed to a decline in TB incidence and mortality rates in many parts of the world. However, challenges remain, particularly in areas with high rates of HIV co-infection or where MDR-TB is prevalent.
